AAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primates
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus (AAV) vectors have been a powerful gene delivery vehicle to the retina for basic research and gene therapy. For many of these applications, achieving cell type-specific targeting and high transduction efficiency is desired. Recently, there has been increasing interest in AAV-mediated gene targeting to specific retinal bipolar cell types. A 200-bp enhancer in combination with a basal SV40 promoter has been commonly used to target transgenes into ON-type bipolar cells. In the current study, we searched for additional cis-regulatory elements in the mGluR6 gene for improving AAV-mediated transduction efficiency into retinal bipolar cells. Our results showed that the combination of the endogenous mGluR6 promoter with additional enhancers in the introns of the mGluR6 gene markedly enhanced AAV transduction efficiency as well as made the targeting more selective for rod bipolar cells in mice. Furthermore, the AAV vectors with the improved promoter could target to ON bipolar cells with robust transduction efficiency in the parafovea and the far peripheral retina of marmoset monkeys. The improved mGluR6 promoter constructs could provide a valuable tool for genetic manipulation in rod bipolar cells in mice and facilitate clinical applications for ON bipolar cell-based gene therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145
ChIP-seq accurately predicts tissue-specific activity of enhancers
Visel, A., Blow, M. J., Li, Z., Zhang, T., Akiyama, J. A., Holt, A., Plajzer-Frick, I., Shoukry, M., Wright, C., Chen, F., et al. (2009) · Nature · doi:10.1038/nature07730 · Cited by 1,639
Dalkara, D., Byrne, L. C., Klimczak, R. R., Visel, M., Yin, L., Merigan, W. H., Flannery, J. G., & Schaffer, D. V. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005708 · Cited by 734
High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors
Petrs-Silva, H., Dinculescu, A., Li, Q., Min, S.-H., Chiodo, V., Pang, J.-J., Zhong, L., Zolotukhin, S., Srivastava, A., Lewin, A. S., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2008.269 · Cited by 398
Inner limiting membrane barriers to aav-mediated retinal transduction from the vitreous
Dalkara, D., Kolstad, K. D., Caporale, N., Visel, M., Klimczak, R. R., Schaffer, D. V., & Flannery, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.181 · Cited by 357
Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina
Petrs-Silva, H., Dinculescu, A., Li, Q., Deng, W.-T., Pang, J.-J., Min, S.-H., Chiodo, V., Neeley, A. W., Govindasamy, L., Bennett, A., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.234 · Cited by 267
A comprehensive review of retinal gene therapy
Boye, S. E., Boye, S. L., Lewin, A. S., & Hauswirth, W. W. (2013) · Molecular Therapy · doi:10.1038/mt.2012.280 · Cited by 262
Intravitreal injection of AAV2 transduces macaque inner retina
Yin, L., Greenberg, K., Hunter, J. J., Dalkara, D., Kolstad, K. D., Masella, B. D., Wolfe, R., Visel, M., Stone, D., Libby, R. T., et al. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6250 · Cited by 212
Restoration of vision with ectopic expression of human rod opsin
Cehajic-Kapetanovic, J., Eleftheriou, C., Allen, A. E., Milosavljevic, N., Pienaar, A., Bedford, R., Davis, K. E., Bishop, P. N., & Lucas, R. J. (2015) · Current Biology · doi:10.1016/j.cub.2015.07.029 · Cited by 184
Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors
Kay, C. N., Ryals, R. C., Aslanidi, G. V., Min, S. H., Ruan, Q., Sun, J., Dyka, F. M., Kasuga, D., Ayala, A. E., Van Vliet, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062097 · Cited by 168
Research works printed but not linked: 39
- Zhu Y, Xu J, Hauswirth WW, DeVries SH . Genetically targeted binary labeling of retinal neurons. J Neurosci 2014; 34: 7845–7861. · DOI · Paper page
- Trapani I, Puppo A, Auricchio A . Vector platforms for gene therapy of inherited retinopathies. Prog Retin Eye Res 2014; 43: 108–128. · DOI · Paper page
- Euler T, Haverkamp S, Schubert T, Baden T . Retinal bipolar cells: elementary building blocks of vision. Nat Rev Neurosci 2014; 15: 507–519. · DOI · Paper page
- Bi A, Cui J, Ma YP, Olshevskaya E, Pu M, Dizhoor AM et al. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron 2006; 50: 23–33. · DOI · Paper page
- Lagali PS, Balya D, Awatramani GB, Munch TA, Kim DS, Busskamp V et al. Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration. Nat Neurosci 2008; 11: 667–675. · DOI · Paper page
- Busskamp V, Picaud S, Sahel JA, Roska B . Optogenetic therapy for retinitis pigmentosa. Gene Therapy 2012; 19: 169–175. · DOI · Paper page
- Pan Z-H, Lu Q, Bi A, Dizhoor AM, Abrams GW . Optogenetic approaches to restoring vision. Annu Rev Vis Sci 2015; 1: 185–210. · DOI
- Ueda Y, Iwakabe H, Masu M, Suzuki M, Nakanishi S . The mGluR6 5’ upstream transgene sequence directs a cell-specific and developmentally regulated expression in retinal rod and ON-type cone bipolar cells. J Neurosci 1997; 17: 3014–3023. · DOI
- Morgan JL, Dhingra A, Vardi N, Wong RO . Axons and dendrites originate from neuroepithelial-like processes of retinal bipolar cells. Nat Neurosci 2006; 9: 85–92. · DOI
- Dhingra A, Sulaiman P, Xu Y, Fina ME, Veh RW, Vardi N . Probing neurochemical structure and function of retinal ON bipolar cells with a transgenic mouse. J Comp Neurol 2008; 510: 484–496. · DOI
- Kim DS, Matsuda T, Cepko CL . A core paired-type and POU homeodomain-containing transcription factor program drives retinal bipolar cell gene expression. J Neurosci 2008; 28: 7748–7764. · DOI · Paper page
- Doroudchi MM, Greenberg KP, Liu J, Silka KA, Boyden ES, Lockridge JA et al. Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness. Mol Ther 2011; 19: 1220–1229. · DOI · Paper page
- Cronin T, Vandenberghe LH, Hantz P, Juttner J, Reimann A, Kacsó AE et al. Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter. EMBO Mol Med 2014; 6: 1175–1190. · DOI · Paper page
- Mace E, Caplette R, Marre O, Sengupta A, Chaffiol A, Barbe P et al. Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV restores ON and OFF visual responses in blind mice. Mol Ther 2015; 23: 7–16. · DOI · Paper page
- Lu Q, Ivanova E, Ganjawala HT, Pan Z-H . Cre-mediated recombination efficiency and transgene expression patterns of three retinal bipolar cell-expressing Cre transgenic mouse lines. Mol Vis 2013; 19: 1310–1320.
- Butler JE, Kadonaga JT . The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev 2002; 16: 2583–2592. · DOI · Paper page
- Papadakis ED, Nicklin SA, Baker AH, White SJ . Promoters and control elements: designing expression cassettes for gene therapy. Curr Gene Ther 2004; 4: 89–113. · DOI · Paper page
- Pennacchio LA, Bickmore W, Dean A, Nobrega MA, Bejerano G . Enhancers: five essential questions. Nat Rev Genet 2013; 14: 288–295. · DOI · Paper page
- Greferath U, Grünert U, Wässle H . Rod bipolar cells in the mammalian retina show protein kinase C-like immunoreactivity. J Comp Neurol 1990; 301: 433–442. · DOI · Paper page
- Huang L, Max M, Margolskee RF, Su H, Masland RH, Euler T . G protein subunit Gγ13 is coexpressed with Gαo, Gβ3, and Gβ4 in retinal ON bipolar cells. J Comp Neurol 2003; 455: 1–10. · DOI
- Chan TL, Martin PR, Clunas N, Grünert U . Bipolar cell diversity in the primate retina: morphologic and immunocytochemical analysis of a new world monkey, the marmoset Callithrix jacchus. J Comp Neurol 2001; 437: 219–239. · DOI
- Weltzien F, Percival KA, Martin PR, Grünert U . Analysis of bipolar and amacrine populations in marmoset retina. J Comp Neurol 2015; 523: 313–334. · DOI
- Surace EM, Auricchio A . Versatility of AAV vectors for retinal gene transfer. Vis Res 2008; 48: 353–359. · DOI
- de Leeuw CN, Dyka FM, Boye SL, Laprise S, Zhou M, Chou AY et al. Targeted CNS delivery using human MiniPromoters and demonstrated compatibility with adeno-associated viral vectors. Mol Ther Methods Clin Dev 2014; 1: 5. · DOI · Paper page
- Scalabrino ML, Boye SL, Fransen KM, Noel JM, Dyka FM, Min SH et al. Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. Hum Mol Genet 2015; 24: 6229–6239. · DOI · Paper page
- Wässle H, Puller C, Müller F, Haverkamp S . Cone contacts, mosaics, and territories of bipolar cells in the mouse retina. J Neurosci 2009; 29: 106–117. · DOI · Paper page
- Strettoi E, Pignatelli V . Modifications of retinal neurons in a mouse model of retinitis pigmentosa. Proc Natl Acad Sci USA 2000; 97: 11020–11025. · DOI · Paper page
- Hibino H, Tani K, Ikebuchi K, Wu MS, Sugiyama H, Nakazaki Y et al. The common marmoset as a target preclinical primate model for cytokine and gene therapy studies. Blood 1999; 93: 2839–2848. · doi:10.1182/blood.v93.9.2839.409k06_2839_2848
- t’Hart BA, Vervoordeldonk M, Heeney JL, Tak PP . Gene therapy in nonhuman primate models of human autoimmune disease. Gene Therapy 2003; 10: 890–901. · DOI
- Ivanova E, Hwang GS, Pan ZH, Troilo D . Evaluation of AAV-mediated expression of Chop2-GFP in the marmoset retina. Investig Ophthalmol Vis Sci 2010; 51: 5288–5296. · DOI · Paper page
- Baba Y, Satoh S, Otsu M, Sasaki E, Okada T, Watanabe S . In vitro cell subtype-specific transduction of adeno-associated virus in mouse and marmoset retinal explant culture. Biochimie 2012; 94: 2716–2822. · DOI
- Troilo D, Howland HC, Judge SJ . Visual optics and retinal cone topography in the common marmoset (Callithrix jacchus. Vision Res 1993; 33: 1301–1310. · DOI · Paper page
- Goodchild AK, Ghosh KK, Martin PR . Comparison of photoreceptor spatial density and ganglion cell morphology in the retina of human, macaque monkey, cat, and the marmoset Callithrix jacchus. J Comp Neurol 1996; 366: 55–75. · DOI · Paper page
- Wilder HD, Grunert U, Lee BB, Martin PR . Topography of ganglion cells and photoreceptors in the retina of a New World monkey: the marmoset Callithrix jacchus. Vis Neurosci 1996; 13: 335–352. · DOI · Paper page
- Hendrickson A, Troilo D, Djajadi H, Possin D, Springer A . Expression of synaptic and phototransduction markers during photoreceptor development in the marmoset monkey Callithrix jacchus. J Comp Neurol 2009; 512: 218–231. · doi:10.1002/cne.21893
- Hendrickson A, Troilo D, Possin D, Springer A . Development of the neural retina and its vasculature in the marmoset Callithrix jacchus. J Comp Neurol 2006; 497: 270–286. · DOI
- Gaub BM, Berry MH, Holt AE, Reiner A, Kienzler MA, Dolgova N et al. Restoration of visual function by expression of a light-gated mammalian ion channel in retinal ganglion cells or ON-bipolar cells. Proc Natl Acad Sci USA 2014; 111: E5574–E5583. · DOI · Paper page
- Gaub BM, Berry MH, Holt AE, Isacoff EY, Flannery JG . Optogenetic vision restoration using rhodopsin for enhanced sensitivity. Mol Ther 2015; 23: 1562–1571. · DOI · Paper page
- Aslanidi GV, Rivers AE, Ortiz L, Song L, Ling C, Govindasamy L et al. Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold? PLoS One 2013; 8: e59142. · DOI · Paper page
Cited by
Jüttner, J., Szabo, A., Gross-Scherf, B., Morikawa, R. K., Rompani, S. B., Hantz, P., Szikra, T., Esposti, F., Cowan, C. S., Bharioke, A., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0431-2 · Cited by 218
Buck, T., & Wijnholds, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124197 · Cited by 92
“[124] In4s-In3e- Grm6-mGluR500P 1997 690 bp shortened Intron 4s + 807 bp Intron 3 + 500 bp mGluR500P [124]”
Advances in gene therapy for diseases of the eye
Petit, L., Khanna, H., & Punzo, C. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.040 · Cited by 82
“While transduction of ganglion and bipolar cells is still difficult in large animal models, novel vectors and promoters with better affinity for the inner retina have been recently reported.(166,169,170) Moreover, good preservation of these cells has been demonstrated in patients with advanced RP and LCA.”
BackgroundVectors and Gene Delivery to the Retina
Planul, A., & Dalkara, D. (2017) · Annual Review of Vision Science · doi:10.1146/annurev-vision-102016-061413 · Cited by 67
Gene Therapy for Inherited Retinal Degeneration
Arbabi, A., Liu, A., & Ameri, H. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0087 · Cited by 30
“48 In another study, it was shown that human rhodopsin kinase (hGRK1) promoter transduces exclusive AAV-mediated expression in photoreceptor cells via subretinal injection in mice and NHPs with unexpected off-target expression in RGCs. 20 In another study, AAV2/5 viral vector containing GRK1…”
InfluentialKoponen, S., Kokki, E., Tamminen, T., & Ylä-Herttuala, S. (2023) · Frontiers in Drug Delivery · doi:10.3389/fddev.2023.1148795 · Cited by 21
Metadata
- Authors
- Lu, Q., Ganjawala, T. H., Ivanova, E., Cheng, J. G., Troilo, D., & Pan, Z.-H.
- Venue
- Gene Therapy
- Published
- 2016-04-26
- Volume
- 23
- Issue
- 8-9
- Pages
- 680-689
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2345139606
- Cited by
- 70
- References
- 11
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.